Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion type Assertion NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_head.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion description "[Our results provide evidence for the feasibility and efficacy of the modification of HSPC with CAR as a strategy for generating multiple lineages of effector cells for immunotherapy against B-lineage malignancies to augment graft-versus-leukemia activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_provenance.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion evidence source_evidence_literature NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_provenance.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion SIO_000772 23978226 NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_provenance.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion wasDerivedFrom befree-20150227 NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_provenance.
- NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_assertion wasGeneratedBy ECO_0000203 NP338500.RAb4Mho6Dbzetv5tzaFUcj4iqEuKbOelXapIqnciLQP3U130_provenance.